VOYA INVESTMENT MANAGEMENT LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1068837 ATLANTA, GA

Position in SPRY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$481,480

+$12,745 QoQ

Shares Held

60,110

+3.0% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#77

of 208 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 0% Shared 20% None 80%

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,483,663,924 across 196 Biotechnology names. SPRY ranks #109 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	505,219	$250,957,432
2	PTGX	Protagonist Therapeutics, Inc	571,618	$70,068,932
3	TWST	Twist Bioscience Corp	671,866	$69,121,573
4	SRRK	Scholar Rock Holding Corp	890,607	$48,983,385
5	KRYS	Krystal Biotech, Inc.	124,442	$46,251,357
6	TGTX	Tg Therapeutics, Inc.	819,253	$45,009,759
7	PTCT	Ptc Therapeutics, Inc.	539,319	$43,992,249
8	PRAX	Praxis Precision Medicines, Inc.	122,227	$40,920,376

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$481,480	60,110	+3.0%	Shares	Defined	2026-08-12
2026-03-31	$468,735	58,373	+71.0%	Shares	Defined	2026-05-12
2025-12-31	$397,590	34,128	-70.3%	Shares	Defined	2026-02-12
2025-09-30	$1,154,271	114,853	-30.9%	Shares	Defined	2025-10-09
2025-06-30	$2,899,910	166,184	+152.9%	Shares	Defined	2025-08-14
2025-03-31	$826,794	65,723	-2.3%	Shares	Defined	2025-06-18
2024-12-31	$709,772	67,277	+40.5%	Shares	Defined	2025-05-02
2024-09-30	$694,492	47,896	+176.7%	Shares	Defined	2025-02-07
2024-06-30	$147,282	17,307	+223.5%	Shares	Defined	2025-02-07
2021-03-31	$233,420	5,350	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.